Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Modernizing stockpiles of medical countermeasures against smallpox: Benefits, risks, and knowledge gaps.

Oleksiewicz MB, Steenhard NR, Hansen JE.

Am J Disaster Med. 2015 Spring;10(2):109-20. doi: 10.5055/ajdm.2015.0195.

PMID:
26312493
2.

Deaths following vaccination: What does the evidence show?

Miller ER, Moro PL, Cano M, Shimabukuro TT.

Vaccine. 2015 Jun 26;33(29):3288-92. doi: 10.1016/j.vaccine.2015.05.023. Epub 2015 May 23. Review.

PMID:
26004568
3.

Clinical guidance for smallpox vaccine use in a postevent vaccination program.

Petersen BW, Damon IK, Pertowski CA, Meaney-Delman D, Guarnizo JT, Beigi RH, Edwards KM, Fisher MC, Frey SE, Lynfield R, Willoughby RE.

MMWR Recomm Rep. 2015 Feb 20;64(RR-02):1-26.

4.

Cytokine production associated with smallpox vaccine responses.

Simon WL, Salk HM, Ovsyannikova IG, Kennedy RB, Poland GA.

Immunotherapy. 2014;6(10):1097-112. doi: 10.2217/imt.14.72. Review.

5.

Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis.

von Sonnenburg F, Perona P, Darsow U, Ring J, von Krempelhuber A, Vollmar J, Roesch S, Baedeker N, Kollaritsch H, Chaplin P.

Vaccine. 2014 Sep 29;32(43):5696-702. doi: 10.1016/j.vaccine.2014.08.022. Epub 2014 Aug 20.

PMID:
25149431
6.

Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.

McNeil MM, Cano M, R Miller E, Petersen BW, Engler RJ, Bryant-Genevier MG.

Vaccine. 2014 Aug 20;32(37):4758-65. doi: 10.1016/j.vaccine.2014.06.034. Epub 2014 Jun 18.

PMID:
24951868
7.

Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis.

Slifka MK, Leung DY, Hammarlund E, Raué HP, Simpson EL, Tofte S, Baig-Lewis S, David G, Lynn H, Woolson R, Hata T, Milgrom H, Hanifin J.

J Allergy Clin Immunol. 2014 Feb;133(2):439-47. doi: 10.1016/j.jaci.2013.10.037. Epub 2013 Dec 10.

8.

The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Keckler MS, Reynolds MG, Damon IK, Karem KL.

Vaccine. 2013 Oct 25;31(45):5192-201. doi: 10.1016/j.vaccine.2013.08.039. Epub 2013 Aug 27. Review.

PMID:
23994378
9.

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.

Frey SE, Winokur PL, Salata RA, El-Kamary SS, Turley CB, Walter EB Jr, Hay CM, Newman FK, Hill HR, Zhang Y, Chaplin P, Tary-Lehmann M, Belshe RB.

Vaccine. 2013 Jun 24;31(29):3025-33. doi: 10.1016/j.vaccine.2013.04.050. Epub 2013 May 9.

10.

Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®).

Tack DM, Karem KL, Montgomery JR, Collins L, Bryant-Genevier MG, Tiernan R, Cano M, Lewis P, Engler RJ, Damon IK, Reynolds MG.

Hum Vaccin Immunother. 2013 Jul;9(7):1489-96. doi: 10.4161/hv.24319. Epub 2013 Apr 9. Review.

PMID:
23571177
11.

Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel.

Levy Y, Anis E, Kaliner E, Grotto I, Danon YL.

Vaccine. 2012 Oct 19;30(47):6632-5. doi: 10.1016/j.vaccine.2012.08.072. Epub 2012 Sep 7.

PMID:
22963804
12.

Eczema vaccinatum.

Reed JL, Scott DE, Bray M.

Clin Infect Dis. 2012 Mar;54(6):832-40. doi: 10.1093/cid/cir952. Epub 2012 Jan 30. Review.

13.

Contact transmission of vaccinia virus from smallpox vaccinees in the United States, 2003-2011.

Wertheimer ER, Olive DS, Brundage JF, Clark LL.

Vaccine. 2012 Feb 1;30(6):985-8. doi: 10.1016/j.vaccine.2011.12.049. Epub 2011 Dec 20.

PMID:
22192851
14.

Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.

Haber P, Iskander J, Walton K, Campbell SR, Kohl KS.

Pediatrics. 2011 May;127 Suppl 1:S39-44. doi: 10.1542/peds.2010-1722G. Epub 2011 Apr 18.

15.

Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications.

Sato H.

Environ Health Prev Med. 2011 Sep;16(5):281-9. doi: 10.1007/s12199-010-0200-z. Epub 2010 Dec 21. Review.

16.

A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.

Zhang CX, Sauder C, Malik T, Rubin SA.

Biologicals. 2010 Mar;38(2):278-83. doi: 10.1016/j.biologicals.2009.09.007. Epub 2009 Nov 6.

17.

Progressive vaccinia in a military smallpox vaccinee - United States, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):532-6.

18.

Post-vaccination encephalomyelitis: literature review and illustrative case.

Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C.

J Clin Neurosci. 2008 Dec;15(12):1315-22. doi: 10.1016/j.jocn.2008.05.002. Epub 2008 Oct 30. Review.

PMID:
18976924
19.

Extracting key information from historical data to quantify the transmission dynamics of smallpox.

Nishiura H, Brockmann SO, Eichner M.

Theor Biol Med Model. 2008 Aug 20;5:20. doi: 10.1186/1742-4682-5-20. Review.

20.

Adverse event related to smallpox vaccination.

Bristol N.

Disaster Med Public Health Prep. 2007 Jul;1(1):11-2. doi: 10.1097/DMP.0b013e3180690d58. No abstract available.

PMID:
18388595
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk